NOACs in Atrial Fibrillation Patients with Polypharmacy-Reference-Cited by-同舟云学术

NOACs in Atrial Fibrillation Patients with Polypharmacy

Published:2023-11-21 Issue:02 Volume:124 Page:149-151
ISSN:0340-6245
Container-title:Thrombosis and Haemostasis
language:en
Short-container-title:Thromb Haemost

Author:

Corica Bernadette¹²,Romiti Giulio Francesco¹²^ORCID,Proietti Marco³⁴^ORCID

Affiliation:

1. Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom

2. Department of Translational and Precision Medicine, Sapienza—University of Rome, Rome, Italy

3. Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

4. Division of Subacute Care, IRCCS Istituti Clinici Scientifici Maugeri, Milan, Italy

Publisher

Georg Thieme Verlag KG

Subject

Hematology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0043-1776900.pdf

Reference25 articles.

1. What is polypharmacy? A systematic review of definitions;N Masnoon;BMC Geriatr,2017

2. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis;M Delara;BMC Geriatr,2022

3. Clinical consequences of polypharmacy in elderly;R L Maher;Expert Opin Drug Saf,2014

4. Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis;K Palmer;Eur Geriatr Med,2019

5. Association between polypharmacy and death: a systematic review and meta-analysis;N Leelakanok;J Am Pharm Assoc (2003),2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombosis and Haemostasis 2023 Editors' Choice Papers;Thrombosis and Haemostasis;2024-01